The innovative, patent-protected VESIsorb® drug delivery system provides the needed scientific evidence that supports improved cannabidiol (CBD) bioavailability in seminal study.

CBG is among the many emerging cannabinoids and terpenes that Geocann is committed to pioneering through its technical formulation expertise and global distribution infrastructure.

The prestigious group is comprised of a multidisciplinary collective with decades of well-documented and published work as well as prominent careers focused on advancing the therapeutic benefits of science-backed natural ingredients, like cannabinoids and terpenes.

Industry-leading solution provider addresses the need to formulate cannabinoids with fast-acting and predictable onset, offering leading brands the ability to deliver the safest and most efficacious food and beverage products to cannabis consumers.